Bionano Genomics announced upgrades to its suite of computational tools for comprehensive cancer analysis. These advancements to the company’s VIA software solution aim to enhance the detection and interpretation of aneusomies, and improve the analysis, visualization, interpretation, and reporting of data types including optical genome mapping, next generation sequencing, and microarray, for comprehensive assessment of hematological diseases. Advancements to the suite of tools include: enhanced detection of critical variants; automated analysis and interpretation of variants; and dynamic visualization for better representation of findings.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BNGO:
- Options Volatility and Implied Earnings Moves Today, May 08, 2024
- Options Volatility and Implied Earnings Moves This Week, May 06 – May 10, 2024
- Bionano Genomics announces publication on OGM’s structural variation detection
- Bionano Genomics enters partnership with Diagens
- Bionano Genomics announces publication showing OGM detects over 1250 variants